The glyoxalase system, and in particular its rate-limiting component Glo1, may be a key determinant of interindividual susceptibility to elevated MGO levels in the setting of hyperglycemia and subsequent development of diabetic complications, as several experimental studies have linked dysfunction of Glo1 to a higher prevalence of diabetes [12]. The gene discussed is GLO1; the disease is diabetes mellitus.